HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

C Ambrogio Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

1/2017In vivo oncogenic conflict triggered by co-existing KRAS and EGFR activating mutations in lung adenocarcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


C Ambrogio Research Topics

Disease

1Neoplasms (Cancer)
01/2017
1Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2013
1Lung Neoplasms (Lung Cancer)
04/2013

Drug/Important Bio-Agent (IBA)

1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2017
1Cytostatic AgentsIBA
01/2017
1tyrosine receptor (receptor, tyrosine)IBA
04/2013
1Phosphotransferases (Kinase)IBA
04/2013

Therapy/Procedure

1Therapeutics
04/2013